Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure is a research paper published in PLoS neglected tropical diseases (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: 1R21AI153545-01
Discovery of new molecular phenotypes for anti-schistosomal drug screening
NIAID NIH HHS
Grant: HHSN272201700014C
NIAID NIH HHS
Grant: R21 AI153545
Therapeutic Accelerator Program
New Faculty Pilot Grant/Medical College of Wisconsin
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals